后TIPS脑病变:临床表现,诊断和管理
Doo Hee Kim1, Hassan Anbari2, Sameer Gadani3
1Department of Radiology, MedStar Georgetown University Hospital, Washington, DC.
Techniques in vascular and interventional radiology
|August 10, 2025
概括
转内肝移植系统分流 (TIPS) 的产生可能导致肝脏脑病变 (HE). 本研究详细介绍了TIPS后增加HE风险的患者和程序因素,并讨论了其管理.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 干预性放射学 干预性放射学
- 胃肠病学 胃肠病学
背景情况:
- 门性高血压的管理往往涉及到跨内肝移植系统 (TIPS) 的创建.
- 肝脏脑病变 (HE) 仍然是TIPS后的一个重要并发症.
- 了解TIPS后的风险因素对于患者护理至关重要.
研究的目的:
- 为了确定与TIPS安置后肝脑病变的发展相关的临床和程序因素.
- 为管理TIPS后发生肝脑病变的患者提供全面的概述.
主要方法:
- 对患者临床状况和TIPS创建参数的审查.
- 分析导致TIPS后肝脏脑病变的可能性的因素.
- 讨论TIPS后肝脏脑病变的当前管理策略.
主要成果:
- 一些患者特异性和程序性因素被确定为增加 TIPS 后肝脏脑病变的风险.
- 详细介绍了TIPS后高等教育的多因素性质.
结论:
- 识别和减轻手术前的风险因素可能会降低 TIPS 后肝脏脑病发病率.
- 有效的管理策略对于TIPS后发展肝脑病变的患者至关重要.
相关概念视频
Acute Pancreatitis II: Clinical Manifestations and Management
176
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
176
Esophageal Varices-II: Clinical Features and Management
139
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
139
Alzheimer's Disease: Overview
668
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
668
Epilepsy and Seizures: Overview
280
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
280
Aneurysm II: Clinical Manifestations and Diagnostic Studies
23
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
23
Alzheimer's Disease: Treatment
261
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
261


